Biosimilars: Regulatory Trends And Manufacturing Considerations

Unlike well-defined chemical medicinal products and their generic counterparts, biologics and their biosimilar counterparts employ sophisticated bioprocessing technologies that utilize living systems for their manufacture. Because these complex heterogeneous protein molecules are produced in living systems, their exact characteristics are subject to inherent batch-to-batch variability.
Read more...

;